Quantitative computed tomography measurements of bone mineral density prepubertal children with congenital hypothyroidism treated with L-thyroxine

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 6, 2004, Pages 889-893

  Pitukcheewanont, Pisit ^a   Safani, David ^a   Gilsanz, Vicente ^a   Klein, Michelle ^a   Chongpison, Yuda ^a   Costin, Gertrude ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bone density; Cancellous; Children; Congenital hypothyroidism; Corticol; Prepubertal; Quantitative computed tomography

Indexed keywords

LEVOTHYROXINE; TECHNETIUM 99M; THYROTROPIN;

ARTICLE; BONE DENSITY; BONE MINERAL; CANCELLOUS BONE; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HYPOTHYROIDISM; CORRELATION ANALYSIS; CORTICAL BONE; DOSE RESPONSE; FEMALE; FEMUR; HUMAN; MALE; MEDICAL RECORD; OSSIFICATION; OSTEOPOROSIS; PREPUBERTY; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THYROID SCINTISCANNING; THYROTROPIN BLOOD LEVEL;

BONE DENSITY; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; RETROSPECTIVE STUDIES; THYROXINE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3242879542     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lukert B, Higgens J, Stoskopf M. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 1986; 62: 1056-1058.
2. Martinez M, Herran L, de Pedro C, Pallardo L. Osteocalcin levels in patients with hyper- and hypothyroidism. Horm Metab Res 1986; 18: 212-214.
3. Fraser S, Smith D, Anderson J, Wilson G. Osteoporosis and fractures following thyrotoxicosis. Lancet 1971; i: 981-983.
4. Mosekilde L, Melsen F, Bagger JP, Myhre-Jensen O, Sorensen NS. Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol (Copenh) 1977; 85: 515-525.
5. Smith D, Fraser S, Wilson G. Hyperthyroidism and calcium metabolism. Clin Endocrinol Metab 1973; 2: 333-354.
6. Linde J, Friis T. Osteoporosis in hyperthyroidism estimated by photon absorptiometry. Acta Endocrinol (Copenh) 1978; 91: 437-448.
7. Ribot C, Tremollieres F, Pouilles JM, Louvet JP. Bone mineral density and thyroid hormone therapy. Clin Endocrinol 1990; 33: 143-153.
8. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone metabolism and mineral metabolism. Endocrinol Metab Clin North Am 1990; 19: 35-63.
9. Langdahl BL, Loft AGR, Eriksen EF, Mosekilde L, Charles P. Bone mass, bone turnover, and body composition in former hypothyroid patients receiving replacement therapy. Eur J Endocrinol 1996; 134: 702-709.
10. Grant D, McMurdo MET, Mole PA, Paterson C, Davies RR. Suppressed TSH levels secondary to thyroxine replacement therapy are not associated with osteoporosis. Clin Endocrinol 1993; 39: 529-533.
11. Franklyn JA, Betteridge J, Daykin J, Holder R, Oates GD, Parle JV, Lilley J, Heath DA, Sheppard MC. Long-term thyroxine treatment and bone mineral density. Lancet 1992; 340: 9-13.
12. Ross DS, Neer RM, Ridgway EC, Daniels GH. Subclinical hyperthyriodism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med 1987; 82: 1167-1170.
13. Leger J, Ruiz J-C, Guibourdenche J, Kindermans C, Garabedian M, Czernichow P. Bone mineral density and metabolism in children with congenital hypothyriodism after prolonged L-thyroxine therapy. Acta Paediatr 1997; 86: 704-710.
14. Kooh SW, Brnjac L, Ehrich RM, Qureshi R, Krishnan S. Bone mass in children with congenital hypothyroidism treated with thyroxine since birth. J Pediatr Endocrinol Metab 1996; 9: 59-62.
15. Weber G, Mora S, Bellini A, Bosco M, Prinster C, Siragusa V, DiNatale B, Chiumello G. Bone mineral metabolism and thyroid replacement therapy in congenital hypothyroid infants and young children. J Endocrinol Invest 1995; 18: 277-282.
16. Ross DS. Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid 1994; 4: 319-326.
17. Gilsanz V, Roe TF, Mora S, Costin G, Goodman WG. Changes in vertebral bone density in Black girls and White girls during childhood and puberty. N Engl J Med 1991; 325: 1597-1600.
18. Arfai K, Pitukcheewanont P, Goran MI, Tavare CJ, Heller L, Gilsanz V. Bone, muscle, and fat: sex-related differences in prepubertal children. Radiology 2002; 224: 338-344.
19. Gilsanz V, Skaggs DL, Kovanlikaya A, Sayre J, Loro ML, Kaufman F, Korenman SG. Differential effect of race on the axial and appendicular skeletons of children. J Clin Endocrinol Metab 1998; 83: 1420-1427.
20. Kalender WA. Effective dose values in bone mineral measurements by photon absorptiometry and computed tomography. Osteoporosis Int 1992; 2: 82-87.
21. Saggese G, Bertelloni S, Baroncelli GI, Costa S, Ceccarelli C. Bone mineral density in adolescent females treated with L-thyroxine: a longitudinal study. Eur J Pediatr 1996; 155: 452-457.
22. Demeester-Mirkine N, Bergmann P, Body J, Corvilain J. Calcitonin and bone mass status in congenital hypothyroidism. Calcif Tissue Int 1990; 46: 222-226.